Evidence map›Paper›PMID 39355632›Full record

ArticleFrontiers in nuclear medicine2021

Fully Automated

Frédérique Blanc-Béguin, Julien Masset, Philippe Robin, Raphaël Tripier, Simon Hennebicq, Valérie Guilloux, Charles Vriamont, Corentin Warnier, Virginie Cogulet, Peter Eu and 2 more

Abstract read
In one paragraph

Article in Frontiers in nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Frédérique Blanc-BéguinMedecine Nucleaire, CHRU Brest, EA3878 (GETBO) IFR 148, Univ Brest, Brest, France.
Julien MassetTrasis Radiopharmacy Instruments, Ans, Belgium.
Philippe RobinMedecine Nucleaire, CHRU Brest, EA3878 (GETBO) IFR 148, Univ Brest, Brest, France.
Raphaël TripierUniv Brest UMR-CNRS 6521 (CEMCA), IFR 148, Brest, France.
Simon HennebicqMedecine Nucleaire, CHRU Brest, EA3878 (GETBO) IFR 148, Univ Brest, Brest, France.
Valérie GuillouxMedecine Nucleaire, CHRU Brest, Brest, France.
Charles VriamontTrasis Radiopharmacy Instruments, Ans, Belgium.
Corentin WarnierTrasis Radiopharmacy Instruments, Ans, Belgium.
Virginie CoguletPharmacie, CHRU Brest, INSERM 1078, Brest, France.
Peter EuCancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Pierre-Yves SalaünMedecine Nucleaire, CHRU Brest, EA3878 (GETBO) IFR 148, Univ Brest, Brest, France.
Pierre-Yves Le RouxMedecine Nucleaire, CHRU Brest, EA3878 (GETBO) IFR 148, Univ Brest, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung PET/CT is a promising imaging modality for regional lung function assessment. Our aim was to develop and validate a fast, simple, and fully automated GMP compliant [

Indexed as

[68Ga]Ga-MAAautomated purificationautomated synthesisgallium-68perfusion PET/CT

Identifiers

PMID39355632
PMCPMC11440869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.